Abstract
Multiple karyotypic abnormalities and chromosomal instability are characteristic features of many cancers that are relatively resistant to chemotherapeutic agents currently used in the clinic. These same features represent potentially targetable “states” that are essentially tumor specific. The assessment of the chromosomal state of a cancer cell population may provide a guide for the selection or development of drugs active against aggressive and intractable cancers.
Keywords: Aneuploidy, Chromosomal instability, Cancer, Anticancer drugs, NCI-60, Karyotic abnormalities, CIN, Chromosomal instability phenotype, Heterogeneity, Cancer progression, Chemotherpeutic agents, Anticancer therapy, Drosophila, Trisomies, Saccharomyces cerevisiae, Schizosaccharomyces pombe, Neoplasia, Tumorigenesis, Microsatellite instability, CENP-E heterozygous, Chromatid cohesion, Centrosomes, Kinetochore, Chromosome missegregating, JAK-STAT signaling pathways, ECM-receptor interaction pathways, Griseofulvin, Cancer spectrum, GI50 data vectors, Anthracyclines, Antifolates, Alkylators, Topoisomerase agents, Gemcitabine, 5-fluorouracil, Mercapto-3H quinazolines
Current Drug Targets
Title: Targeting Karyotypic Complexity and Chromosomal Instability of Cancer Cells
Volume: 11 Issue: 10
Author(s): Anna V. Roschke and Ilan R. Kirsch
Affiliation:
Keywords: Aneuploidy, Chromosomal instability, Cancer, Anticancer drugs, NCI-60, Karyotic abnormalities, CIN, Chromosomal instability phenotype, Heterogeneity, Cancer progression, Chemotherpeutic agents, Anticancer therapy, Drosophila, Trisomies, Saccharomyces cerevisiae, Schizosaccharomyces pombe, Neoplasia, Tumorigenesis, Microsatellite instability, CENP-E heterozygous, Chromatid cohesion, Centrosomes, Kinetochore, Chromosome missegregating, JAK-STAT signaling pathways, ECM-receptor interaction pathways, Griseofulvin, Cancer spectrum, GI50 data vectors, Anthracyclines, Antifolates, Alkylators, Topoisomerase agents, Gemcitabine, 5-fluorouracil, Mercapto-3H quinazolines
Abstract: Multiple karyotypic abnormalities and chromosomal instability are characteristic features of many cancers that are relatively resistant to chemotherapeutic agents currently used in the clinic. These same features represent potentially targetable “states” that are essentially tumor specific. The assessment of the chromosomal state of a cancer cell population may provide a guide for the selection or development of drugs active against aggressive and intractable cancers.
Export Options
About this article
Cite this article as:
V. Roschke Anna and R. Kirsch Ilan, Targeting Karyotypic Complexity and Chromosomal Instability of Cancer Cells, Current Drug Targets 2010; 11 (10) . https://dx.doi.org/10.2174/1389450111007011341
DOI https://dx.doi.org/10.2174/1389450111007011341 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Call for Papers in Thematic Issues
Drug-Targeted Approach with Polymer Nanocomposites for Improved Therapeutics
Polymer nanocomposites have been recognized as an advanced and cutting-edge technique in drug targeting administration. These materials combine the unique features of nanoparticles with the adaptability of polymers to produce highly personalized drug administration devices. Integrating nanoparticles containing pharmaceuticals into a polymer matrix enables researchers to regulate the rates at ...read more
New drug therapy for eye diseases
Eyesight is one of the most critical senses, accounting for over 80% of our perceptions. Our quality of life might be significantly affected by eye disease, including glaucoma, diabetic retinopathy, dry eye, etc. Although the development of microinvasive ocular surgery reduces surgical complications and improves overall outcomes, medication therapy is ...read more
Therapeutic Chemical and RNA Design with Artificial Intelligence
Computer-Aided Drug Design (CADD) has emerged as a fundamental component of modern drug discovery. Molecular docking facilitates virtual screening on a large scale through structural simulations. However, traditional CADD approaches face significant limitations, as they can only screen known compounds from existing libraries. PubChem, as the most widely used chemical ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
PLK1 Inhibition: Prospective Role for the Treatment of Pediatric Tumors
Current Drug Targets ABC Transporters in the Development of Multidrug Resistance in Cancer Therapy
Current Pharmaceutical Design P53 Family: At the Crossroads in Cancer Therapy
Current Medicinal Chemistry Non-traumatic Limping in the Child: A Pediatric Rheumatologist Perspective on Etiology, Clinical Evaluation, Laboratory Diagnosis, and Diagnostic Algorithms using Musculoskeletal Ultrasound (MSUS)
Current Pediatric Reviews The Potential Therapeutic Impact of Metformin in Glioblastoma Multiforme
Current Medicinal Chemistry Momordicacharantia: A New Strategic Vision to Improve the Therapy of Endoplasmic Reticulum Stress
Current Pharmaceutical Design Perspectives of Plant Natural Products in Inhibition of Cancer Invasion and Metastasis by Regulating Multiple Signaling Pathways
Current Medicinal Chemistry A Systematic Review of Genes Involved in the Inverse Resistance Relationship Between Cisplatin and Paclitaxel Chemotherapy: Role of BRCA1
Current Cancer Drug Targets Heparan Sulfate Proteoglycans, Tumour Progression and the Cancer Stem Cell Niche
Current Cancer Therapy Reviews Fanconi Anemia DNA Repair Pathway as a New Mechanism to Exploit Cancer Drug Resistance
Mini-Reviews in Medicinal Chemistry Vanadium, Ruthenium and Copper Compounds: A New Class of Nonplatinum Metallodrugs with Anticancer Activity
Current Medicinal Chemistry The Intriguing Interplay Between Therapies Targeting the Epidermal Growth Factor Receptor, the Hypoxic Microenvironment and Hypoxia-inducible Factors
Current Pharmaceutical Design Negative Regulation of NEDD8 Conjugation Pathway by Novel Molecules and Agents for Anticancer Therapy
Current Pharmaceutical Design Ewing’s Sarcoma Cancer Stem Cell Targeted Therapy
Current Stem Cell Research & Therapy Nanostructured Calcium-based Biomaterials and their Application in Drug Delivery
Current Medicinal Chemistry Piper Sarmentosum: A New Hope for the Treatment of Osteoporosis
Current Drug Targets Gene Expression Studies in Multiple Sclerosis
Current Genomics microRNA Biogenesis Pathway as a Therapeutic Target for Human Disease and Cancer
Current Pharmaceutical Design Pleiotrophin as a Possible New Target for Angiogenesis-Related Diseases and Cancer
Recent Patents on Anti-Cancer Drug Discovery Advancement of Targeted Ultrasound Contrast Agents and their Applications in Molecular Imaging and Targeted Therapy
Current Pharmaceutical Design